Rare Immune Disorders Sharply Raise Cancer Risk, Study Finds

Patients with inborn errors of immunity face significantly elevated risk of developing non-blood cancers, a new clinical analysis reveals. The finding could reshape screening protocols and treatment strategies for this vulnerable population, with implications for pharmaceutical development and healthcare resource allocation.

Originaltitel: Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity